These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27051967)

  • 1. Myofibroblasts have an impact on expression, dimerization and signaling of different ErbB receptors in OSCC cells.
    Büttner R; Berndt A; Valkova C; Richter P; Korn A; Kosan C; Liebmann C
    J Recept Signal Transduct Res; 2017 Feb; 37(1):25-37. PubMed ID: 27051967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of activated fibroblasts on phenotype modulation, EGFR signalling and cell cycle regulation in OSCC cells.
    Berndt A; Büttner R; Gühne S; Gleinig A; Richter P; Chen Y; Franz M; Liebmann C
    Exp Cell Res; 2014 Apr; 322(2):402-14. PubMed ID: 24394543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells.
    Choi BK; Fan X; Deng H; Zhang N; An Z
    Cancer Med; 2012 Aug; 1(1):28-38. PubMed ID: 23342251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer.
    Fichter CD; Timme S; Braun JA; Gudernatsch V; Schöpflin A; Bogatyreva L; Geddert H; Faller G; Klimstra D; Tang L; Hauschke D; Werner M; Lassmann S
    Int J Cancer; 2014 Oct; 135(7):1517-30. PubMed ID: 24510732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-HER-An antibody mixture targeting EGFR, HER2 and HER3 abrogates preformed and ligand-induced EGFR homo- and heterodimers.
    Ellebaek S; Brix S; Grandal M; Lantto J; Horak ID; Kragh M; Poulsen TT
    Int J Cancer; 2016 Nov; 139(9):2095-105. PubMed ID: 27342948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-β1 mediated by podoplanin.
    Li YY; Zhou CX; Gao Y
    Exp Cell Res; 2018 Aug; 369(1):43-53. PubMed ID: 29719198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures.
    Bagordakis E; Sawazaki-Calone I; Macedo CC; Carnielli CM; de Oliveira CE; Rodrigues PC; Rangel AL; Dos Santos JN; Risteli J; Graner E; Salo T; Paes Leme AF; Coletta RD
    Tumour Biol; 2016 Jul; 37(7):9045-57. PubMed ID: 26762409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation.
    Gu J; Chen L; Shatos MA; Rios JD; Gulati A; Hodges RR; Dartt DA
    Exp Eye Res; 2008 Feb; 86(2):322-34. PubMed ID: 18155194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.
    Chen R; Jin G; Li W; McIntyre TM
    J Immunol; 2018 Oct; 201(7):2154-2164. PubMed ID: 30150285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma.
    Costea DE; Hills A; Osman AH; Thurlow J; Kalna G; Huang X; Pena Murillo C; Parajuli H; Suliman S; Kulasekara KK; Johannessen AC; Partridge M
    Cancer Res; 2013 Jul; 73(13):3888-901. PubMed ID: 23598279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.
    Kanemaru A; Yamamoto K; Kawaguchi M; Fukushima T; Lin CY; Johnson MD; Camerer E; Kataoka H
    Int J Cancer; 2017 Jan; 140(1):130-141. PubMed ID: 27615543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER3 intracellular domains play a crucial role in HER3/HER2 dimerization and activation of downstream signaling pathways.
    Choi BK; Cai X; Yuan B; Huang Z; Fan X; Deng H; Zhang N; An Z
    Protein Cell; 2012 Oct; 3(10):781-9. PubMed ID: 22983903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
    Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
    Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells.
    Iwase M; Takaoka S; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M
    Oral Oncol; 2008 Apr; 44(4):361-8. PubMed ID: 17689285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of epidermal growth factor receptor/protein kinase B signaling in the tumor intrinsic PD-L1-induced malignant potential of oral squamous cell carcinoma.
    Sasabe E; Tomomura A; Yamamoto T
    J Oral Pathol Med; 2024 May; 53(5):310-320. PubMed ID: 38693616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone modulates ErbB tyrosine kinase expression and signaling through multiple and redundant mechanisms in cultured rat hepatocytes.
    Scheving LA; Buchanan R; Krause MA; Zhang X; Stevenson MC; Russell WE
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G552-9. PubMed ID: 17585012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of somatostatin receptor 1 and 5 on epidermal growth factor receptor mediated signaling.
    Kharmate G; Rajput PS; Watt HL; Somvanshi RK; Chaudhari N; Qiu X; Kumar U
    Biochim Biophys Acta; 2011 Jun; 1813(6):1172-89. PubMed ID: 21419811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors.
    Hudelist G; Singer CF; Manavi M; Pischinger K; Kubista E; Czerwenka K
    Breast Cancer Res Treat; 2003 Aug; 80(3):353-61. PubMed ID: 14503808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells.
    Erjala K; Sundvall M; Junttila TT; Zhang N; Savisalo M; Mali P; Kulmala J; Pulkkinen J; Grenman R; Elenius K
    Clin Cancer Res; 2006 Jul; 12(13):4103-11. PubMed ID: 16818711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.